Searching journal content for articles similar to Därr et al. 23 (12): 899.

Displaying results 1-7 of 7
For checked items
  1. Commentary:
    • Rodrigo Almeida Toledo
    New HIF2α inhibitors: potential implications as therapeutics for advanced pheochromocytomas and paragangliomas Endocr Relat Cancer 24 (9) C9-C19, doi:10.1530/ERC-16-0479 first published on 30 June 2017
    ...detected in patients with pheochromocytoma/paraganglioma-polycythemia. Journal of Molecular Medicine 93 93–104. (doi:10.1007/s00109-014-1205-7) Yang C, Hong CS, Prchal JT, Balint MT, Pacak K & Zhuang Z 2015b Somatic mosaicism of EPAS1 mutations in the syndrome of paraganglioma and somatostatinoma...
  2. Thematic Review:
    • Arthur S Tischler and
    • Ronald R deKrijger
    15 YEARS OF PARAGANGLIOMA: Pathology of pheochromocytoma and paraganglioma Endocr Relat Cancer 22 (4) T123-T133, doi:10.1530/ERC-15-0261 first published on 1 July 2015
    ...also been reported both in association with mutations of another Kreb’s cycle gene, fumarate hydratase (Clark et al. 2014), and mutations of TMEM127 (Qin et al. 2014, Hernandez et al. 2015). A new syndrome of paraganglioma andduodenal somatostatinoma associated with polycythemia Published...
  3. Research Letter:
    • Zhengping Zhuang,
    • Chunzhang Yang,
    • Ales Ryska,
    • Yuan Ji,
    • Yingyong Hou,
    • Sky D Graybill,
    • Petra Bullova,
    • Irina A Lubensky,
    • Günter Klöppel,
    • and Karel Pacak
    HIF2A gain-of-function mutations detected in duodenal gangliocytic paraganglioma Endocr Relat Cancer 23 (5) L13-L16, doi:10.1530/ERC-16-0148 first published on 29 April 2016
    ...2 alpha (HIF2A) mutations are responsible for a newly discovered syndrome of multiple paragangliomas (PGL) and duodenal somatostatinomas associated with polycythemia (Pacak–Zhuang syndrome) (Zhuang et  al. 2012, Pacak et  al. 2013, Toyoda et  al. 2014). In this syndrome, found exclusively in females...
  4. Research:
    • Jenny Welander,
    • Adam Andreasson,
    • Michael Brauckhoff,
    • Martin Bäckdahl,
    • Catharina Larsson,
    • Oliver Gimm,
    • and Peter Söderkvist
    Frequent EPAS1/HIF2α exons 9 and 12 mutations in non-familial pheochromocytoma Endocr Relat Cancer 21 (3) 495-504, doi:10.1530/ERC-13-0384 first published on 16 April 2014
    ...with polycythemia and paraganglioma (Lorenzo et al. 2013) which, just like the first mutations identified, was demonstrated to decrease ubiquitination and degradation, thereby increasing the stability of HIF2a. Subsequent studies identified somatic EPAS1 mutations in pheochromocytomas and paragangliomas also...
  5. Research:
    • Aguirre A de Cubas,
    • L Javier Leandro-García,
    • Francesca Schiavi,
    • Veronika Mancikova,
    • Iñaki Comino-Méndez,
    • Lucía Inglada-Pérez,
    • Manuel Perez-Martinez,
    • Nuria Ibarz,
    • Pilar Ximénez-Embún,
    • Elena López-Jiménez,
    • Agnieszka Maliszewska,
    • Rocío Letón,
    • Álvaro Gómez Graña,
    • Carmen Bernal,
    • Cristina Álvarez-Escolá,
    • Cristina Rodríguez-Antona,
    • Giuseppe Opocher,
    • Javier Muñoz,
    • Diego Megias,
    • Alberto Cascón,
    • and Mercedes Robledo
    Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways Endocr Relat Cancer 20 (4) 477-493, doi:10.1530/ERC-12-0183 first published on 9 May 2013
    ...Agnieszka Maliszewska1, Rocı´o Leto´n1, A´lvaro Go´mez Gran˜a1, Carmen Bernal6, 7 1,3 2,8 Correspondence should be addressed to M Robledo Email [email protected] profiles are known to depend on genetic background, a number of questions related to Key Words " pheochromocytoma " paraganglioma " micro...
  6. Research:
    • Rodrigo A Toledo,
    • Yuejuan Qin,
    • Subramanya Srikantan,
    • Nicole Paes Morales,
    • Qun Li,
    • Yilun Deng,
    • Sang-Woo Kim,
    • Maria Adelaide A Pereira,
    • Sergio P A Toledo,
    • Xiaoping Su,
    • Ricardo C T Aguiar,
    • and Patricia L M Dahia
    In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas Endocr Relat Cancer 20 (3) 349-359, doi:10.1530/ERC-13-0101 first published on 26 March 2013
    ...regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genetics 1 72–80. (doi:10.1371/journal.pgen.0010008) Favier J, Buffet A & Gimenez-Roqueplo AP 2012 HIF2A mutations in paraganglioma with polycythemia. New England Journal of Medicine 367 2161 (author reply 2161–2162). (doi:10...
  7. Commentary:
    • Eamonn R Maher
    HIF2 and endocrine neoplasia: an evolving story Endocr Relat Cancer 20 (3) C5-C7, doi:10.1530/ERC-13-0146 first published on 7 May 2013
    ..., Rahimpour S, Prchal JT, Lechan R, Lonser R, Pacak K & Zhuang Z 2013 Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas. Blood 121 2563–2566. (doi:10.1182/ blood-2012-10-460972) Yao L, Barontini M, Niederle B, Jech M, Pfragner R & Dahia PL 2010...
For checked items

Search Results

New Search

Modify Results

Citation format:
Results / page:
Results order:

This search

  • Alert me when new articles matching this search are published
  • Download all citations on this page to my citation manager

New Articles: issue in progress

  1. December 2017, 24 (12)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most